Suppr超能文献

[Clinical evaluation of anticancer therapy combined with p-aminobenzoic acid-N-xyloside].

作者信息

Fujimoto S, Ishigami H, Okui K

出版信息

Gan To Kagaku Ryoho. 1982 Sep;9(9):1574-9.

PMID:6985199
Abstract

Paraaminobenzoic acid-N-xyloside (K-247) is a new antitumor drug, which has no direct effect on immunologic status. Clinical trial of K-247 was performed in 8 patients with for advanced or recurred gastrointestinal cancer, who had short life expectancy. Oral administration of K-247, 600 to 900 mg/day, was carried out in combination with antitumor treatments using MMC, FT-207, 5-FU, PSK or irradiation. No toxic symptoms were observed in all patients. Of the 8 patients studied, one showed an encouraging response, while the remaining 7 patients were too far advanced to respond to these treatments.

摘要

相似文献

3
[Clinical trial of K-247].
Gan To Kagaku Ryoho. 1982 Dec;9(12):2122-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验